Literature DB >> 22290574

Diabetes. Can tight glycemic control in diabetes benefit cognition?

Raimund I Herzog1, Robert S Sherwin.   

Abstract

Intensive glucose management, if begun early, diminishes the long-term complications of diabetes. Whether the cognitive domain also benefits from such therapy is not clear, and has remained subject to investigation. Do the new results from the ACCORD-MIND study settle the issue?

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22290574      PMCID： PMC5515668          DOI： 10.1038/nrneurol.2012.10

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


  10 in total

1.  Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.

Authors:  Lenore J Launer; Michael E Miller; Jeff D Williamson; Ron M Lazar; Hertzel C Gerstein; Anne M Murray; Mark Sullivan; Karen R Horowitz; Jingzhong Ding; Santica Marcovina; Laura C Lovato; James Lovato; Karen L Margolis; Patrick O'Connor; Edward W Lipkin; Joy Hirsch; Laura Coker; Joseph Maldjian; Jeffrey L Sunshine; Charles Truwit; Christos Davatzikos; R Nick Bryan
Journal:  Lancet Neurol       Date:  2011-09-28       Impact factor: 44.182

2.  R D Lawrence Lecture 2010. The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia.

Authors:  M W J Strachan
Journal:  Diabet Med       Date:  2011-02       Impact factor: 4.359

3.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

4.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

5.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

6.  Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus.

Authors:  Rachel A Whitmer; Andrew J Karter; Kristine Yaffe; Charles P Quesenberry; Joseph V Selby
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

7.  Insulin-induced hypoglycemia and its effect on the brain: unraveling metabolism by in vivo nuclear magnetic resonance.

Authors:  Raimund I Herzog; Robert S Sherwin; Douglas L Rothman
Journal:  Diabetes       Date:  2011-07       Impact factor: 9.461

8.  Biomarkers of renal function and cognitive impairment in patients with diabetes.

Authors:  Anne M Murray; Joshua I Barzilay; James F Lovato; Jeff D Williamson; Michael E Miller; Santica Marcovina; Lenore J Launer
Journal:  Diabetes Care       Date:  2011-06-29       Impact factor: 19.112

9.  The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.

Authors:  Michael E Miller; Denise E Bonds; Hertzel C Gerstein; Elizabeth R Seaquist; Richard M Bergenstal; Jorge Calles-Escandon; R Dale Childress; Timothy E Craven; Robert M Cuddihy; George Dailey; Mark N Feinglos; Farmarz Ismail-Beigi; Joe F Largay; Patrick J O'Connor; Terri Paul; Peter J Savage; Ulrich K Schubart; Ajay Sood; Saul Genuth
Journal:  BMJ       Date:  2010-01-08

10.  Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial.

Authors:  Gail Musen; Alan M Jacobson; Christopher M Ryan; Patricia A Cleary; Barbara H Waberski; Katie Weinger; William Dahms; Meg Bayless; Nancy Silvers; Judith Harth; Neil White
Journal:  Diabetes Care       Date:  2008-07-07       Impact factor: 19.112
  10 in total
  6 in total

1.  Diabetes in midlife and cognitive change over 20 years: a cohort study.

Authors:  Andreea M Rawlings; A Richey Sharrett; Andrea L C Schneider; Josef Coresh; Marilyn Albert; David Couper; Michael Griswold; Rebecca F Gottesman; Lynne E Wagenknecht; B Gwen Windham; Elizabeth Selvin
Journal:  Ann Intern Med       Date:  2014-12-02       Impact factor: 25.391

2.  Association of Hypoglycemia With Subsequent Dementia in Older Patients With Type 2 Diabetes Mellitus.

Authors:  Hemalkumar B Mehta; Vinay Mehta; James S Goodwin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-08-01       Impact factor: 6.053

3.  Cognitive Function and Control of Type 2 Diabetes Mellitus in Young Adults.

Authors:  Satyajeet Roy; Nami Kim; Anjali Desai; Mahathi Komaragiri; Namrata Baxi; Navinder Jassil; Megan Blessinger; Maliha Khan; Robert Cole; Nayan Desai; Rocco Terrigno; Krystal Hunter
Journal:  N Am J Med Sci       Date:  2015-05

4.  Investigating the role of neuropathic pain relief in decreasing gait variability in diabetes mellitus patients with neuropathic pain: a randomized, double-blind crossover trial.

Authors:  Surshen Karmakar; Houman Rashidian; Cynthia Chan; CaiXia Liu; Cory Toth
Journal:  J Neuroeng Rehabil       Date:  2014-08-20       Impact factor: 4.262

5.  A novel palmitic acid hydroxy stearic acid (5-PAHSA) plays a neuroprotective role by inhibiting phosphorylation of the m-TOR-ULK1 pathway and regulating autophagy.

Authors:  Jian-Tao Wang; Zhong-Yu Yu; Ying-Hong Tao; Ying-Chao Liu; Yan-Mei Wang; Qi-Lin Guo; Jian-Zhong Xue; Xiao-Hong Wen; Qian Zhang; Xiao-Die Xu; Cheng-Feng He; Wen-Jiao Xue; Jing-Chun Guo; Hou-Guang Zhou
Journal:  CNS Neurosci Ther       Date:  2021-01-18       Impact factor: 5.243

6.  Functional MRI signal fluctuations: a preclinical biomarker for cognitive impairment in type 2 diabetes?

Authors:  Renata Belfort-Deaguiar; R Todd Constable; Robert S Sherwin
Journal:  Diabetes       Date:  2014-02       Impact factor: 9.461
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.